Newsletter October 2017: NOT BORN WITH IT
A recently published clinical trial at Duke University has demonstrated that the majority of children diagnosed with autism spectrum disorder (ASD) are NOT BORN WITH IT.
The team at Duke University treated 25 children with ASD with their own banked umbilical cord blood. The majority (2/3rds) of the children treated with their own umbilical cord blood improved in social communication, use of expressive vocabulary and eye-tracking measures. Some of the children had dramatic improvements so that autism no longer consumes 75% of their family’s daily routine, but now only 10%.
Umbilical cord blood banking is the storing of a child’s cord blood for future uses such as autologous (self) stem cell transplants, applicable for treatments of cancer and other diseases. To treat cancer, high dose chemotherapy or radiation is used, which destroys the child’s blood cells in addition to killing the cancer. The child’s banked umbilical cord blood, which contains blood forming stem cells, is used to help their blood recover quickly to prevent infection. However, if the child was born with the mutation that led to their cancer they would not be able to use the child’s banked cord blood because the cord blood would have the same cancerous mutation.
Over the past decade, numerous studies have been published that demonstrate that 60-70% or more of children diagnosed with simplex ASD have de novo gene mutations that damage critical genes needed for metabolism, cell-cell signaling and other important cell functions. The mutations that have been found in children with ASD were found by sequencing the DNA in the child’s whole blood. De novo gene mutations are mutations that are not present in either parent’s whole blood. The scientific community has assumed, without doing any studies, that the de novo gene mutations must have occurred in the egg, sperm or during early in utero development. Dawson and team’s recent clinical trial treating children with ASD with their own umbilical cord blood reveals the danger of erroneous conclusions and misguided research focus when scientists make assumptions without doing the research to prove their assumptions.
This clinical trial clearly shows us that the mutations found in the whole blood of children with ASD must have occurred after birth. What this means is that research should be focused on identifying environmental damage that happens after birth that leads to the mutations most scientists accept as the cause of the symptoms of autism.
Autism is now a worldwide epidemic. Recently reported rates for India are that autism affects 1 in 68 children. Rates of autism in Africa, Asia and Southeast Asia are almost as high as in the US and EU. Autism struck third world countries affecting children right after humanitarian vaccination campaigns in those countries took place. The Duke University study should be a wake-up call to all of us. The primary trigger for the worldwide autism epidemic must be an environmental exposure that occurs after birth. The commonality among children around the world is that they are now almost universally vaccinated with measles vaccines that are manufactured using human fetal cells and contaminated with human fetal DNA fragments that are well established as inducers of de novo gene mutations.
Why support SCPI? Because SCPI is the only organization doing the hard research to determine the environmental trigger for autism to protect our children and prevent future incidence of vaccine-induced brain injury. And, with our sister organization AVM Biotechnology, we are determined to provide the parents with promising affordable treatments, and hopefully, cures for these children./.